Prevention and treatment of child and adolescent depression: Challenges and opportunities

Epidemiology and Psychiatric Sciences

Volumn 20, Issue 1, 2011, Pages 37-43

  Vitiello, B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

children; depression; prevention; treatment

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ARTICLE; CHILD; COGNITIVE THERAPY; DEPRESSION; HUMAN; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; HUMANS; RECURRENCE; TREATMENT OUTCOME;

EID: 79959799188     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796011000102     Document Type: Review

References (48)

1. Birmaher B, Brent D, the AACAP Work Group on Quality Issues (2007). Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry 46, 1503-1526.
2. Brent D, Emslie G, Clarke G, Wagner K, Asarnow J, Keller M, Vitiello B, Ritz L, Iyengar S, Abebe K, Birmaher B, Ryan N, Kennard B, Hughes C, DeBar L, McCracken J, Strober M, Suddath R, Spirito A, Leonard H, Porta G, Onorato M, Zelazny J (2008). The Treatment of Adolescents with SSRI-Resistant Depression (TORDIA). A comparison of switch to venlafaxine or to another SSRI, with or without additional cognitive behavioral therapy. Journal of the American Medical Association 299, 901-913. (Pubitemid 351397065)
3. Brent D, Greenhill LL, Compton S, Emslie G, Wells K, Walkup J, Vitiello B, Bukstein O, Stanley B, Posner K, Kennard BD, Cwik M, Wagner A, Coffey B, March J, Riddle M, Goldstein T, Curry J, Barnett S, Capasso L, Zelazny J, Hughes J, Shen S, Gugga S, Turner JB (2009). The Treatment of Adolescent Suicide Attempters Study (TASA): Predictors of suicidal events in an open treatment trial. Journal of the American Academy of Child and Adolescent Psychiatry 48, 987-996.
4. Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA (2009). Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. American Journal of Psychiatry 166, 42-49.
5. Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association 297, 1683-1696.
6. Byford S, Barrett B, Roberts C, Wilkinson P, Dubicka B, Kelvin RG, White L, Ford C, Breen S, Goodyer I (2007). Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression. British Journal of Psychiatry 191, 521-527. (Pubitemid 350273213)
7. Centers for Disease Control and Prevention (2006). The 10 Leading Causes of Death, United States. National Center for Injury Prevention and Control (http://webappa.cdc.gov/cgi-bin/broker.exe).
8. Clarke GN, Hornbrook M, Lynch F, Polen M, Gale J, Beardslee W, O'Connor E, Seeley J (2001). A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Archives of General Psychiatry 58, 1127-1134. (Pubitemid 33121504)
9. Copeland WE, Shanahan L, Costello EJ, Angold A (2009). Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Archives of General Psychiatry 66, 764-772.
10. Costello EJ, Erkanli A, Angold A (2006). Is there an epidemic of child and adolescent depression? Journal of Child Psychology and Psychiatry 47, 1263-1271. (Pubitemid 44824722)
11. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry 60, 837-844. (Pubitemid 36960915)
12. Curry JF, Rohde P, Simons A, Silva S, Vitiello B, Kratochvil CJ, Reinecke MA, Feeny N, Wells KC, Pathak S, Weller E, Rosenberg D, Kennard BD, Robins M, Ginsburg GS, March JS (2006). Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry 45, 1427-1439. (Pubitemid 44900916)
13. Domino ME, Foster EM, Vitiello B, Kratochvil CJ, Burns BJ, Silva SG, Reinecke RA, March JS (2009). The relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry 48, 711-720.
14. Emslie G, Mayes T, Porta G, Vitiello B, Clarke G, Wagner KD, Asarnow JR, Spirito A, Birmaher B, Ryan N, Kennard B, DeBar L, McCracken JT, Strober M, Onorato M, Zelazny J, Keller M, Iyengar S, Brent DA (2010). Treatment of resistant depression in adolescents (TORDIA): Week 24 outcomes. American Journal of Psychiatry 167, 782-791.
15. Emslie GJ, Kennard BD, Mayes TL, Nightingale-Teresi J, Carmody T, Hughes CW, Rush AJ, Tao R, Rintelmann JW (2008). Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. American Journal of Psychiatry 165, 459-467. (Pubitemid 351694289)
16. Fergusson DM, Horwood LJ, Ridder EM, Beautrais AL (2005). Subthreshold depression in adolescence and mental health outcomes in adulthood. Archives of General Psychiatry 62, 66-72. (Pubitemid 40096072)
17. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R (2009). Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology 77, 775-787.
18. Garber J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TR, DeBar LL, Lynch FL, D'Angelo E, Hollon SD, Shamseddeen W, Iyengar S (2009). Prevention of depression in at-risk adolescents: A randomized controlled trial. Journal of the American Medical Association 301, 2215-2224.
19. Gibbons RD, Hur K, Bhaumik DK, Mann JJ (2006). The relationship between antidepressant prescription rates and rate of early adolescent suicide. American Journal of Psychiatry 163, 1-7.
20. Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R (2007). Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: Randomized controlled trial. British Medical Journal 335, 142.
21. Hammad TA, Laughren T, Racoosin J (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 63, 332-339. (Pubitemid 43345358)
22. Hollon SD, Stewart MO, Strunk D (2006). Enduring effects of cognitive behavior therapy in the treatment of depression and anxiety. Annual Review of Psychology 57, 285-315. (Pubitemid 43237234)
23. Ising M, Lucae S, Biner EB, Bettecken T, Uhr M, Ripke S, Kohli MA, Hennings JM, Horstmann S, Kloiber S, Menke A, Bondy B, Rupprecht R, Domschke K, Baune BT, Arolt V, Rush AJ, Holsboer F, Müller-Myhsok B (2009). A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Archives of General Psychiatry 66, 966-975.
24. Kennard B, Silva SG, Tonev S, Rohde P, Hughes JL, Vitiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke M, March J (2009). Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): Acute and long-term outcomes. Journal of the American Academy of Child and Adolescent Psychiatry 48, 186-195.
25. Kennard BD, Emslie GJ, Mayes TL, Nightingale-Teresi J, Nakonezny PA, Hughes JL, Jones JM, Tao R, Stewart SM, Jarrett RB (2008). Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 47, 1395-1404.
26. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, Ustün TB, Wang PS (2009). The global burden of mental disorders: An update from the WHO World Mental Health (WMH) surveys. Epidemiologia e Psichiatria Sociale 18, 23-33.
27. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 593-602. (Pubitemid 40973434)
28. Lynch FL, Hornbrook M, Clarke GN, Perrin N, Polen MR, O'Connor E, Dickerson J (2005). Cost-effectiveness of an intervention to prevent depression in at-risk teens. Archives of General Psychiatry 62, 1241-1248. (Pubitemid 41586923)
29. March JS, Vitiello B (2009). Clinical messages from the Treatment for Adolescents with Depression Study (TADS). American Journal of Psychiatry 166, 1118-1123.
30. Mathers C, Boerma T, Ma Fat D (2005). The global burden of disease: 2004 update. World Health Organization Press (http://www.who.int/healthinfo/global- burden-disease/GBD-report-2004update-full.pdf).
31. Merikangas KR, He J-P, Brody D, Fisher PW, Bourdon K, Koretz DS (2010). Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES. Pediatrics 125, 75-81.
32. Owens PL, Thompson J, Elixhauser A, Ryan K (2003). Care of Children and Adolescents in U.S. Hospitals. Agency for Healthcare Research and Quality: Rockville, MD. HCUP Fact Book N0.4, AHRQ Publication No. 04-0004.
33. Regeer EJ, Krabbendam L, de Graaf R, Ten Have M, Nolen WA, van Os J (2006). A prospective study of the transition rates of subthreshold (hypo) mania and depression in the general population. Psychological Medicine 36, 619-627.
34. Sourander A, Klomek AB, Niemelä S, Haavisto A, Gyllenberg D, Helenius H, Sillanmäki L, Ristkari T, Kumpulainen K, Tamminen T, Moilanen I, Piha J, Almqvist F, Gould MS (2009). Childhood predictors of completed and severe suicide attempts: findings from the Finnish 1981 Birth Cohort Study. Archives of General Psychiatry 66, 398-406.
35. Stanley B, Brown G, Brent D, Wells K, Poling K, Curry J, Kennard BD, Wagner A, Cwik M, Klomek AB, Goldstein T, Vitiello B, Barnett S, Daniel S, Hughes J (2009). Cognitive-Behavioral Therapy for Suicide Prevention (CBT-SP): Treatment model, feasibility, and acceptability. Journal of the American Academy of Child and Adolescent Psychiatry 48, 1005-1013.
36. TADS Team (2004). The Treatment for Adolescents with Depression Study (TADS): Short-term effectiveness and safety outcomes. Journal of the American Medical Association 292, 807-820.
37. TADS Team (2007). The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry 64, 1132-1144.
38. TADS Team (2009). The Treatment for Adolescents with Depression Study (TADS): Outcomes over one year of naturalistic follow-up. American Journal of Psychiatry 166, 1141-1149.
39. U.S. Preventive Services Task Force (2009). Screening and treatment for major depressive disorder in children and adolescents: US preventive services task force recommendation statement. Pediatrics 123, 1223-1228.
40. Vitiello B (2009). Combined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: Does it improve outcomes compared with monotherapy? CNS Drugs 23, 271-280.
41. Vitiello B, Brent D, Greenhill LL, Emslie G, Wells K, Walkup JT, Stanley B, Bukstein O, Kennard BD, Compton S, Coffey B, Cwik MF, Posner K, Wagner A, March JS, Riddle M, Goldstein T, Curry J, Capasso L, Mayes T, Shen S, Gugga SS, Turner JB, Barnett S, Zelazny J (2009a). Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters Study (TASA). Journal of the American Academy of Child and Adolescent Psychiatry 48, 997-1004.
42. Vitiello B, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, Birmaher B, Ryan N, Kennard B, Mayes T, DeBar L, Lynch F, Dickerson J, Strober M, Suddath R, McCracken JT, Spirito A, Onorato M, Zelazny J, Porta G, Iyengar S, Brent D (2010). Long-term outcome of adolescent depression initially resistant to SSRI treatment. Journal of Clinical Psychiatry. [Epub ahead of Print on Nov. 16]
43. Vitiello B, Pearson JL (2008). An adolescent at high risk for suicidal behavior. American Journal of Psychiatry 165, 323-328. (Pubitemid 351704486)
44. Vitiello B, Rohde P, Silva SG, Wells KC, Casat C, Waslick BD, Simons A, Reinecke MA, Weller EB, Kratochvil CJ, Walkup J, Pathak S, Robins M, March JS (2006). Effects of treatment on level of functioning, global health, and quality of life in depressed adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 45, 1419-1426. (Pubitemid 44900915)
45. Vitiello B, Silva S, Rohde P, Kratochvil C, Kennard B, Reinecke M, Mayes T, Posner K, May DE, March JS (2009b). Suicidal events in the Treatment for Adolescents with Depression Study (TADS). Journal of Clinical Psychiatry 70, 741-747.
46. Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Trivedi MH, Rush AJ (2006). STA.R.*D-Child Team. Remissions in maternal depression and child psychopathology: A STA.R.*D-child report. Journal of the American Medical Association 295, 1389-1398.
47. Weisz JR, McCarthy CA, Valeri SM (2006). Effects of psychotherapy for depression in children and adolescents: A meta-analysis. Psychological Bulletin 132, 132-149. (Pubitemid 43172355)
48. Zimmermann P, Brückl T, Nocon A, Pfister H, Lieb R, Wittchen HU, Holsboer F, Angst J (2009). Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Archives of General Psychiatry 66, 1341-1352.